Retaining HIV-infected patients in care: Where are we? Where do we go from here?
about
Illicit drug use is a significant risk factor for loss to follow up in patients with HIV-1 infection at a large urban HIV clinic in TokyoHigh prevalence of illicit drug use in men who have sex with men with HIV-1 infection in JapanProvider-Level and Other Health Systems Factors Influencing Engagement in HIV Care: A Qualitative Study of a Vulnerable PopulationPPACA and Low-Income People Living with HIV: 2014 Qualified Health Plan Enrollment in a Medicaid Nonexpansion State.Secondary prevention of HIV in the United States: past, current, and future perspectives.Using HIV surveillance data to monitor missed opportunities for linkage and engagement in HIV medical care.Enhanced Collection of Laboratory Data in HIV Surveillance Among 5 States with Confidential Name-based HIV Infection Reporting, 2005-2006Potential Impact of Integrating HIV Surveillance and Clinic Data on Retention-in-Care Estimates and Re-Engagement EffortsAccess to HIV Care and Support Services for African American Transwomen Living with HIVUsing the multiphase optimization strategy (MOST) to optimize an HIV care continuum intervention for vulnerable populations: a study protocol.It's a Process: Reactions to HIV Diagnosis and Engagement in HIV Care among High-Risk Heterosexuals.Immunologic status and virologic outcomes in repeat pregnancies to HIV-positive women not on antiretroviral therapy at conception: a case for lifelong antiretroviral therapy?The RSVP Project: Factors Related to Disengagement From Human Immunodeficiency Virus Care Among Persons in San Francisco.Motivational barriers to retention of at-risk young adults in HIV-prevention interventions: perceived pressure and efficacy.HIV-Infected Individuals Who Delay, Decline, or Discontinue Antiretroviral Therapy: Comparing Clinic- and Peer-Recruited CohortsEvaluating the Impact of a HIV Low-Risk Express Care Task-Shifting Program: A Case Study of the Targeted Learning RoadmapFactors associated with returning to HIV care after a gap in care in New York State.From access to engagement: measuring retention in outpatient HIV clinical care.Population-based monitoring of HIV drug resistance in Namibia with early warning indicators.Factors associated with patterns of plural healthcare utilization among patients taking antiretroviral therapy in rural and urban South Africa: a cross-sectional study.Beyond core indicators of retention in HIV care: missed clinic visits are independently associated with all-cause mortality.Access to healthcare, HIV/STI testing, and preferred pre-exposure prophylaxis providers among men who have sex with men and men who engage in street-based sex work in the US.Retention in care among HIV-infected patients in resource-limited settings: emerging insights and new directions.Disparities in CD4+ T-Lymphocyte Monitoring Among Human Immunodeficiency Virus-Positive Medicaid Beneficiaries: Evidence of Differential Treatment at the Point of Care.Missed opportunities: refusal to confirm reactive rapid HIV tests in the emergency departmentHigh levels of heterogeneity in the HIV cascade of care across different population subgroups in British Columbia, CanadaFactors associated with retention and viral suppression among a cohort of HIV+ women of color.Improvements in HIV care engagement and viral load suppression following enrollment in a comprehensive HIV care coordination programLinkage and retention in HIV care among men who have sex with men in the United States.Health care system and policy factors influencing engagement in HIV medical care: piecing together the fragments of a fractured health care delivery system.HIV care visits and time to viral suppression, 19 U.S. jurisdictions, and implications for treatment, prevention and the national HIV/AIDS strategy.Impact of age on retention in care and viral suppressionComparative value of four measures of retention in expert care in predicting clinical outcomes and health care utilization in HIV patients.Comparative mortality among people diagnosed with HIV infection or AIDS in the U.S., 2001-2010Incidence rate of and factors associated with loss to follow-up in a longitudinal cohort of antiretroviral-treated HIV-infected persons: an AIDS Clinical Trials Group (ACTG) Longitudinal Linked Randomized Trials (ALLRT) analysis.Barriers and facilitators to patient retention in HIV care.Comparable sustained virologic suppression between community- and academic-based HIV care settingsHIV Care Continuum for HIV-Infected Emergency Department Patients in an Inner-City Academic Emergency DepartmentSorting through the lost and found: are patient perceptions of engagement in care consistent with standard continuum of care measures?Antiretroviral Therapy Adherence and Use of an Electronic Shared Medical Record Among People Living with HIV
P2860
Q28535181-8BC28464-2334-4C34-8E57-C632706ACB4EQ28536725-EE82E690-567C-4C4D-A20B-178A5FCA3A48Q28552668-F76CE4B6-337F-4AA6-993F-FE87F7B893B3Q30276684-8A918651-8823-4056-B105-06FEFA356DAEQ30499536-146A5054-74E5-4DFC-8252-C5463956835CQ30572715-40B776F7-391D-4C2A-8F56-A0DD66C8FC5CQ30573011-7F782144-BCD7-4279-BA73-D0D27C6A09D9Q31128135-81D1236D-92F4-479D-B401-D7FB3610F2A9Q33576649-B2F5D21A-EBBA-46E6-8728-2A956ADB8AF9Q33640486-4652F540-DF34-46C5-94DE-00468FE67B50Q33653802-91CDDEFE-ADA7-4A03-B7DD-6C7F8A8D9F50Q33654652-ACC15BD4-0C90-416F-AAF0-BB80CA60E267Q33708783-169C2A91-A10F-412E-BF80-970184244F29Q33864564-399D3B5A-4844-4B1F-9088-403B0211B8D8Q33907350-261D6536-AF30-4C9B-8620-8E9053DD838CQ33922137-4EBC09D6-D9D9-4DE5-A21F-47245F8C82B5Q33997340-A633E4AD-2EAA-4E06-99BD-946135B46C10Q34249254-D4BD46EF-5802-4778-9320-72EF6B27FB60Q34283361-8E67D3F6-52AD-4798-8BCB-0109EBF969F3Q34322419-46CDED9B-9EC7-44FB-827D-EF42DF11D256Q34430170-642B8DC4-FCA0-4561-9027-F3EB30B0426EQ34489373-987D5E30-CCBF-48C7-A8E3-2E8BBCC7C570Q34495138-D2728DAA-9DC6-4E65-8499-ADEE41514B15Q34508737-A52E705D-B044-4883-B2C3-93908A89697DQ34545039-D288EA10-3601-4BC4-992B-F309CD58BFEAQ34776035-0FA5188D-85D6-4E3C-B4E2-F32F3E8CBCF7Q34811406-47B09F01-5624-40D5-B49B-AF47A1592547Q34974485-AC0FB1BA-4332-401C-B6D7-7AA186C5D70AQ35019895-B9F948F5-CC54-48E9-BAB9-3CCC721CD59AQ35019905-07CCEE62-96E1-4FB8-8A38-523CC0137A7BQ35082924-F2771260-BCEB-460B-AD35-9BEE5E39932DQ35102343-86A529E3-A9C6-4031-8285-E0D4929CF754Q35202689-E18B46CC-5327-43C1-9E1E-789F3B6D4D90Q35299458-C753F80E-ED6D-492A-BE49-1CC5C305DA7FQ35513989-2C7B8663-1994-46FA-A13C-CD02A4005BD2Q35677927-2EF0E465-0103-42A0-AB53-8A34753C01D3Q35684507-9C8269D5-9503-480D-9E85-22D0E4B4E389Q35772424-EA8E7236-208D-4A07-9B78-ADF72C17351BQ35780070-09605E36-030E-40A2-A6A7-E59B81948B7CQ35836811-4727E018-E040-4A55-AC95-7F69EC5BF303
P2860
Retaining HIV-infected patients in care: Where are we? Where do we go from here?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Retaining HIV-infected patients in care: Where are we? Where do we go from here?
@en
Retaining HIV-infected patients in care: Where are we? Where do we go from here?
@nl
type
label
Retaining HIV-infected patients in care: Where are we? Where do we go from here?
@en
Retaining HIV-infected patients in care: Where are we? Where do we go from here?
@nl
prefLabel
Retaining HIV-infected patients in care: Where are we? Where do we go from here?
@en
Retaining HIV-infected patients in care: Where are we? Where do we go from here?
@nl
P2093
P356
P1476
Retaining HIV-infected patients in care: Where are we? Where do we go from here?
@en
P2093
Bruce D Agins
Elizabeth Horstmann
Fareesa Islam
Jillian Brown
Johanna Buck
P304
P356
10.1086/649933
P407
P577
2010-03-01T00:00:00Z